Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
FTC sues three largest UnitedHealth, Cigna, and CVS over high insulin prices
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug costs have skyrocketed over the past decade thanks in part to powerful PBMs and their greed,
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and steering patients toward higher-cost insulin products to increase their profits.
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.
FTC sues pharmaceutical middlemen, claiming practices inflated insulin cost
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming unfair practices inflated the cost of insulin.
6h
Jim Cramer Says UnitedHealth Group Inc. (UNH) Is An ‘Unusual Rate Cut Winner’
We recently compiled a list of the Jim Cramer’s 10 Best Stocks to Buy After Fed Rate Cut. In this article, we are going to ...
4h
on MSN
Is UnitedHealth Group Incorporated (UNH) the Best Stock to Invest in for Medium Term?
We recently compiled a list of the 7 Best Stocks to Invest in for Medium Term. In this article, we will look at where ...
2d
UnitedHealth Group Inc. stock outperforms competitors despite losses on the day
This was the stock's second consecutive day of losses.
7h
Is UnitedHealth Group Incorporated's (NYSE:UNH) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
UnitedHealth Group (NYSE:UNH) has had a great run on the share market with its stock up by a significant 19% over ...
Zacks.com on MSN
3d
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?
UnitedHealth Group Incorporated UNH is currently viewed as expensive, with the stock trading at a 19.09X forward 12-month ...
3d
UnitedHealth Group Inc. stock underperforms Thursday when compared to competitors
UnitedHealth Group Inc. closed $30.87 below its 52-week high ($607.94), which the company achieved on September 4th.
3d
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
10d
UnitedHealth Group: Cyberattack Is Manageable, Initiate With A 'Strong Buy'
UnitedHealth's aggressive M&A strategy and focus on data analytics drive growth and margin improvements, justifying a 'Strong ...
6d
What the Options Market Tells Us About UnitedHealth Group
The general mood among these heavyweight investors is divided, with 38% leaning bullish and 44% bearish. Among these notable ...
Modern Healthcare
4d
UnitedHealth Group's Optum to lay off 160 employees
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
11d
UnitedHealth Group: Reaches Near All-Time High But Still Looks Like A 'Buy' (Rating Upgrade)
UnitedHealth Group had been stumbling through the first half of 2024 with bad news after bad news. Read why I upgrade UNH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback